Repare Therapeutics Inc. Common Shares
Market Cap
110M
Short interest (Jan 15)
1.0%
Net Short (Jan 27 ): -0.2%
Borrow Fee
2.31%
Available Shares
0
Price Chart
Company Overview
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.